ACTH

Cortrophin Gel Now Widely Available in US for Acute Relapses

ANI Pharmaceuticals has announced the full U.S. commercial availability of Cortrophin Gel (repository corticotropin injection), an injectable therapy approved for managing acute relapses in people with multiple sclerosis (MS) and other autoimmune disorders. ā€œPatients with certain chronic autoimmune conditions often need additional treatment options,ā€ Mary Pao Seideman, MD,…

Cortrophin Gel Now Available in US at AllianceRx Walgreens Prime

Cortrophin Gel (repository corticotropin injection), an injectable gel medication approved for acute flares in multiple sclerosis (MS) and other chronic autoimmune diseases, is now available through the AllianceRx Walgreens Prime specialty pharmacy to patients living in the U.S. First approved by the U.S. Food and Drug Administration (FDA)…

Analysis Finds Acthar Gel Cost-effective for MS Relapses

Acthar Gel (repository corticotropin injection) was found to be a cost-effective treatment for people with multiple sclerosis (MS) experiencing a relapse, according to an economic analysis. Notably, the economic value of Acthar Gel was greater than that of alternative treatments ā€”Ā plasmapheresis and intravenous immunoglobulin ā€” from the…

FDA to Review ANI’s Request for Cortrophin Gel Use

The U.S. Food and Drug Administration (FDA) has agreed to review ANI Pharmaceuticalsā€™ supplemental new drug application for the approval of Cortrophin Gel to treat people with multiple sclerosis (MS) and other chronic inflammatory conditions, including rheumatoid arthritis. Purified Cortrophin Gel (repository corticotropin injection USP) is a purified…